096760 — JW Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Market Cap
KR₩227bn
Enterprise Value
KR₩892bn
Revenue
KR₩928bn

Annual income statement for JW Holdings, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	726,424	781,515	788,937	864,536	928,072
Cost of Revenue
Gross Profit	283,590	307,278	344,179	399,959	446,157
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	725,473	711,765	720,641	766,460	820,085
Operating Profit	951	69,749	68,296	98,076	107,987
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-28,623	23,598	32,488	70,995	53,390
Provision for Income Taxes
Net Income After Taxes	-34,178	3,385	4,435	46,482	31,026
Minority Interest
Net Income Before Extraordinary Items
Net Income	-35,982	9,064	-2,778	22,152	19,026
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-35,982	9,064	-2,778	22,152	19,026
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-494	-158	-24.8	353	559
Dividends per Share